Introduction
In 1817, James Parkinson first described a disease, later to be known as Parkinson’s Disease (PD) as a; neurodegenerative disorder affecting the physical, psychological, social, and functional status of individuals (Parkinson Society Canada Staff, 1965). In the time since the disease was first described, the frequency of individuals affected with the disease has increased, with no single cause yet to be identified as the culprit for the onset of the disease. According to the Parkinson’s society Society of Canada, approximately one hundred thousand Canadians live with this debilitating disease (Parkinson Society Canada Staff, 1965). Not only has no successful cure for Parkinson’s been developed, there has yet to be any diagnostic tools developed that prove any suredefinite diagnosis (Parkinson Society Canada Staff, 1965). To this point, Parkinson’s is a disease that continues to impact a higher percentage of the population each year, with no true hope being given to those that struggle with the impairment. The purpose of this paper is to provide a summary of our knowledge on PD to date, describing the physiology behind the deficits that PD is responsible for, the known causes and risk factors, the signs and symptoms, and finally any known treatments that help to reduce the impairments of PD.
Physiology
The origin of the impairments of PD disease start in the basal ganglia, the basal ganglia in laymen terms would be defined as the basic cluster of nuclei, located
Parkinson’s is a progressive neurodegenerative disease, primarily affecting voluntary, precise, and controlled movement. Parkinson’s occurs when cells in a part of the brain called the substantia nigra die off. These cells are responsible for producing dopamine. With less and less dopamine, a person has less and less ability to regulate their movements, body and emotions. The terms "familial Parkinson's disease" and "sporadic Parkinson's disease" are used to differentiate genetic from truly idiopathic forms of the disease.
Although the etiology of idiopathic Parkinson's disease (PD) is unknown, it is characterized by the loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) of ventral midbrain region [9]; [1]. Its prevalence is associated with age. Approximately 1% of the population is affected at 65–70 years of age, which increases to 4–5% in 85-year-olds [2]. Various epidemiological studies and pathological analyses have demonstrated that mean age of onset in sporadic PD, which accounts for about 95% of cases of Parkinsonism is 70 years [7]; [3]. Familial form of Parkinson’s disease is linked to genetic mutations and has prevalence rate of 4%. Familial Parkinson’s disease patients develop early-onset disease before the age of 50
Ramig and colleagues (2001) performed a study to examine the long-term effects of using Lee Silverman Voice Treatment (LSVT) to improve vocal function in individuals with Parkinson’s Disease (PD). Ramig and colleagues (2001) compared LSVT to received respiratory therapy (RET) to control for extraneous variables. Subjects were recruited from a variety of sources which helped to reduce recruitment bias (Ramig et al., 2001). Individuals with any laryngeal pathology unrelated to PD were excluded from the study (Ramig et al., 2001). All 33 subjects were stratified based on: age, time post-diagnosis, stage of disease, score on the unified Parkinson’s disease rating scale, and clinical ratings on speech and voice severity (Ramig et al., 2001). Subjects were then randomly divided into 2 groups and received either LSVT or RET provided in four one-hour weekly sessions for four weeks (Ramig et al., 2001).
Parkinson’s disease (PD) is the second most common neurodegenerative disease. Two other names for PD are shaking palsy and Paralysis agitans. Parkinson’s disease is initiated when the cells in the brain that produce dopamine die over time. Dopamine is a brain chemical used by nerve cells that helps to control the body 's muscle movement. Without those brain cells and the dopamine they produce, it becomes increasingly more difficult for the cells that control movement to send messages to the muscles; affecting the body’s movement. As time goes on the damage worsens. There is not a known cause as to why these brain cells die, although there are a few theories ("MedlinePlus Medical Encyclopedia:
Parkinson’s Disease (PD), "the shaking palsy" first described by James Parkinson in 1817, is a progressive neurodegenerative disorder which affects in upwards of 1.5 million Americans. The disease begins to occur around age 40 and has incidence with patient age. One survey found that PD may affect 1% of the population over 60. Incidence seems to be more prominent in men, and tends to progress to incapacity and death over one or two decades.
When the neurons die, they produce something called dopamines. A dopamine is a neurotransmitter. They send messages to the brain that disrupts coordination and movement. The part of the brain that the neurons are affected is called the substantia nigra. The substantia nigra is in the brain stem, right above the spinal cord. These parts are essential to the functioning of the central nervous system. With the progression of this disease, the dopamine levels decrease, and the person is unable to control their movement . (http://www.pdf.org/about_pd)
Parkinson’s disease is a progressive disorder that affects the nervous system, specifically the movement. The most common and most notable symptom is the tremor. The tremor is often found in the arm or hand. Symptoms of Parkinson’s have appeared throughout history. In India, as early as 5000 B.C. certain symptoms of Parkinson’s have showed up. Scientists and researchers have developed many treatments and medications for this disease. Although there are these treatments and medications, there is no permanent cure to Parkinson’s. Current research is still being done to find a cure, and they have found that if a person is healthy when diagnosed they have the potential to live as long as someone who is unaffected by this disease. Parkinson’s
Parkinson’s Disease (PD), known for its degenerative abilities and debilitating affects, is an illness that affects approximately 1 million Americans. The cause of this disease has not been pinpointed, although strides have been made towards a cure. As our elderly population increases, so does our overwhelming need to find a suitable cure that may one day eliminate this disease.
Parkinson’s Disease (PD) is a chronic neurodegenerative disease that affects approximately ten million people worldwide (Hellqvist & Berterö, 2015). Unfortunately, the cause of PD is still unknown. However, PD’s pathology involves degeneration in noradrenergic, serotonergic, and dopaminergic pathways (Hellqvist & Berterö, 2015). In addition, abnormally folded Lewy bodies form nodules in brain cells and infect healthy neurons (Hellqvist & Berterö, 2015). PD causes motor and cognitive impairments which include tremor, postural instability, depression, and anxiety (Chenoweth, Sheriff, McAnally, & Tait, 2013). PD is one of the most debilitating and costly chronic diseases in the world, and could have serious
Parkinson’s disease is a neurological disorder that is classified as a movement disorder (Pinel, 2013). Parkinson’s disease is a progressive disease, meaning it does more damage over time. Many people may believe that Parkinson’s is an uncommon disease, however it affects as much as 1 percentage of the population over the age of 60 (Shafique, Blagrove, Chung, & Logendrarajah, 2011). Surprisingly, men are two and a half times more likely to develop Parkinson’s over women (Pinel, 2013). Parkinson’s is a disease that dramatically impacts those who suffer from it. Parkinson’s disease affects every part of a patient’s life, including personal and professional, health, and all matters pertaining to the quality of life. While
Parkinson’s disease is a chronic brain disorder that limits mobility in patients that are diagnosed with it. Information about the disease was first published in Western medicine in 175 AD, although evidence of it it has been seen since earlier ancient times. Since then, much has been learned about the disease. In the 1960s, the differences in chemicals in the brains of Parkinson’s disease patients were first identified. Researchers now believe that Parkinson’s is caused by the gradual breakdown of nerve cells in the brain. The degeneration of these cells leads to a lack of dopamine in the brain, which makes nerve functioning more difficult as it is harder for the brain to coordinate muscle movement. The gradual breakdown of neurons causes the symptoms of Parkinson’s to worsen as the patient gets older. Since the 1960s, research on Parkinson’s has been ongoing but not yet conclusive.
Parkinson’s disease (PD) is a neurodegenerative debilitating movement disease which gets worse over time (Medscape, 2015). After much research and study no known cause has yet been determined and experts have hypothesized that it is a mix of inherited and environmental factors (Medscape, 2015). However, regardless of the unspecific cause, it is characterized by a significant loss in dopamine transportation to the basal ganglia which manifests itself in the three following physiologic signs: resting tremor, rigidity and bradykinesia (slow and reduced movement) (Mahan, Escott-Stump & Raymond, 2012). In North America PD is one of the most prevalent neurological disorders affecting relatively 1% of persons older than 65 years of age and within 5 years 66% of patients are disabled and by 10 years 80% are disabled (Mahan et al., 2012). PD increases in incidence with age, is not partial to socioeconomic status, is more common in whites than in Asian or Blacks and is predominately seen between the ages of 40 and 70 (Mahan et al., 2012).
Parkinson’s disease is a nervous system disorder that affects movement, speech, and other brain function due to insufficient amounts of dopamine release. It is currently incurable, however there are some treatments that can be given to a patient depending on their symptoms and how severe they are. These treatments are administered to Parkinson’s disease patients with the goal of controlling symptoms and minimizing their affects for as long as possible as the disease progresses. Parkinson’s disease is still being researched however, and many treatments are considered experimental. Current treatments that are being administered include dopamine drugs, speech and physical therapy, and in more severe cases, deep brain stimulating surgery. Moreover,
This paper will discuss Parkinson’s disease the cause, signs and symptoms, early detection, common associated effects, treatment, solutions to environmental and genetic effects, and illness prevention strategies. While covering all these topics we will discuss how important it is to know about this disease and how we can better treat this disease to help our loved ones when they are diagnosed with Parkinson’s disease.
Parkinson disease (PD) is a progressive neurodegenerative disorder characterized mainly by physical and psychological disabilities. This disorder was named after James Parkinson, an English physician who first described it as shaking palsy in 1817 (Goetz, Factr, and Weiner, 2002). Jean- Martin Charcot, who was a French neurologist, then progressed and further refined the description of the disease and identified other clinical features of PD (Goetz, Factr, and Weiner, 2002). PD involves the loss of cells that produce the neurotransmitter dopamine in a part of the brain stem called the substansia nigra, which results in several signs and symptoms (Byrd, Marks, and Starr, 2000). It is manifested clinically by tremor,